Patient self-management in primary care patients with mild COPD - protocol of a randomised controlled trial of telephone health coaching by Sidhu, Manbinder S et al.
 
 
Patient self-management in primary care patients
with mild COPD - protocol of a randomised
controlled trial of telephone health coaching
Sidhu, Manbinder; Daley, Amanda; Jordan, Rachel; Coventry, Peter A; Heneghan, Carl;
Jowett, Sue; Singh, Sally; Marsh, Jennifer; Adab, Peymane; Varghese, Jinu; Nunan, David;
Blakemore, Amy; Stevens, Jenny; Dowson, Lee; Fitzmaurice, David; Jolly, Kate
DOI:
10.1186/s12890-015-0011-5
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Sidhu, MS, Daley, A, Jordan, R, Coventry, PA, Heneghan, C, Jowett, S, Singh, S, Marsh, J, Adab, P, Varghese,
J, Nunan, D, Blakemore, A, Stevens, J, Dowson, L, Fitzmaurice, D & Jolly, C 2015, 'Patient self-management in
primary care patients with mild COPD - protocol of a randomised controlled trial of telephone health coaching',
BMC Pulmonary Medicine, vol. 15, 16. https://doi.org/10.1186/s12890-015-0011-5
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly credited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Checked July 2015
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
Sidhu et al. BMC Pulmonary Medicine  (2015) 15:16 
DOI 10.1186/s12890-015-0011-5STUDY PROTOCOL Open AccessPatient self-management in primary care patients
with mild COPD – protocol of a randomised
controlled trial of telephone health coaching
Manbinder S Sidhu1, Amanda Daley2, Rachel Jordan3, Peter A Coventry4, Carl Heneghan5, Sue Jowett6,
Sally Singh7, Jennifer Marsh3, Peymane Adab3, Jinu Varghese3, David Nunan5, Amy Blakemore4, Jenny Stevens8,
Lee Dowson9, David Fitzmaurice2 and Kate Jolly3*Abstract
Background: The prevalence of diagnosed chronic obstructive pulmonary disease (COPD) in the UK is 1.8%,
although it is estimated that this represents less than half of the total disease in the population as much remains
undiagnosed. Case finding initiatives in primary care will identify people with mild disease and symptoms. The
majority of self-management trials have identified patients from secondary care clinics or following a hospital
admission for exacerbation of their condition. This trial will recruit a primary care population with mild symptoms
of COPD and use telephone health coaching to encourage self-management.
Methods/Design: In this study, using a multi-centred randomised controlled trial (RCT) across at least 70 general
practices in England, we plan to establish the effectiveness of nurse-led telephone health coaching to support
self-management in primary care for people who report only mild symptoms of their COPD (MRC grade 1 and 2)
compared to usual care. The intervention focuses on taking up smoking cessation services, increasing physical
activity, medication management and action planning and is underpinned by behavioural change theory. In total,
we aim to recruit 556 patients with COPD confirmed by spirometry with follow up at six and 12 months. The primary
outcome is health related quality of life using the St Georges Respiratory Questionnaire (SGRQ). Spirometry and BMI
are measured at baseline. Secondary outcomes include self-reported health behaviours (smoking and physical activity),
physical activity measured by accelerometery (at 12 months), psychological morbidity, self-efficacy and cost-effectiveness
of the intervention. Longitudinal qualitative interviews will explore how engaged participants were with the intervention
and how embedded behaviour change was in every day practices.
Discussion: This trial will provide robust evidence about the effectiveness of a novel telephone health coaching
intervention to promote behaviour change and prevent disease progression in patients with mild symptoms of
dyspnoea in primary care.
Trial registration: Current controlled trials ISRCTN06710391.
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Epidemiology and costs of COPD
Chronic obstructive pulmonary disease (COPD) is a chronic
progressive disease with an increasing burden on the NHS
and society. The prevalence of diagnosed COPD in the
United Kingdom (UK) is 1.8% [1], although it is estimated
that this under-represents the burden of disease, [2-4]
with the global prevalence estimated as 5-10% [5]. In the
UK, COPD accounts for at least 1.4 million consultations
with general practitioners (GPs), 1 million in-patient days
annually, high health care costs (largely driven by in-
patient costs for people with severe disease) [6], and is a
leading cause of death [7]. Increasing recognition of the
importance of this disease [8,9] culminated in a new
National Clinical Outcomes Strategy in 2011 in the UK [10].
Self-management of COPD
‘Self-management’ has been defined as “the ability of a pa-
tient to deal with all that a chronic disease entails, including
symptoms, treatment, physical and social consequences
and lifestyle changes” [11]. For COPD, the important self-
management health behaviours are: smoking cessation,
adherence to medication; early recognition of symptoms;
prompt access to treatments during an exacerbation (ac-
tion planning), breathing techniques, bronchial hygiene
techniques, exercise, nutritional programmes and stress
management [12-14]. The importance of the different ele-
ments will vary according to the severity of the condition.
The UK National Clinical Outcomes Strategy recom-
mends early identification of COPD in people [10], thus
there is a need for identifying interventions that will main-
tain function in people with mild symptoms of COPD.
With the exception of smoking cessation, few such inter-
ventions have been proposed, much less adequately
trialled. Clearly smoking cessation is important and while
there is some evidence that pharmacological interventions
(i.e. varenicline) improve cessation among mild to moder-
ate COPD [15] there is little work on behavioural inter-
ventions among this population and people generally
prefer non-drug interventions. One effective behavioural
intervention for smoking in COPD was led by GPs, which
is not a practicable or feasible way to deliver these types of
interventions in primary care; it was also tested in China
so may well have limited external validity [16]. Based largely
on observational evidence [17,18] promotion of physical
activity should also be a key component of any interven-
tion. Physical activity declines in patients with COPD,
even those with mild disease (GOLD stage 2) and people
with mild symptoms (MRC grade 2) [19]. Large-scale ob-
servational studies report an association between higher
levels of physical activity in people with COPD and re-
duced hospital admissions and all-cause mortality, even
when adjusted for severity [20,21]. A systematic review of
five small trials evaluating the effectiveness of physicalactivity programmes in people with mild/moderate COPD
reported improved exercise capacity, but had no effect on
dyspnoea or quality of life [22], but other evidence from
pulmonary rehabilitation programmes in this group do
show improvements of these outcomes [23]. Other import-
ant elements for patients with mild dyspnoea are likely to
be adherence to medication and action planning at the first
signs of a chest infection/exacerbation and exercise.
Effectiveness of self-management support for COPD
The most recent Cochrane systematic review of self-
management interventions [24] (excluding studies on
pulmonary rehabilitation) reported that self-management
interventions, with significant support from health care
workers, delivered to COPD patients in the stable state
could significantly reduce hospital admissions compared
with usual care (OR 0.60; 95% CI 0.40 to 0.89, 6 studies)
and significantly improve health related quality of life
(HRQoL) (mean difference in SGRQ −3.51, 95% CI −5.37
to −1.65, 10 studies). This effect was larger than seen in a
previous review of limited self-management education
alone [25] and approaches the minimally clinically import-
ant difference of 4 points [26].
A systematic review of five trials on the effectiveness
of action plans only (with only limited education) found
that although patients were significantly more likely to
recognise exacerbations and initiate treatment, there was
no reduction in healthcare utilisation, and the authors
concluded that a more significant self-management ap-
proach might be needed [27]. A further systematic review
of COPD disease management programmes [28] including
10 trials and three before/after studies indicated that such
programmes (which often include self-management com-
ponents) may decrease hospital admissions and improve
quality of life, although further exploration of the elements
that bring the greatest benefit are needed.
The majority of trials of self-management have identi-
fied patients from secondary care clinics or following a
hospital admission for exacerbation of their condition.
These patients have more severe disease and are not rep-
resentative of primary care patients, many of whom will
have mild COPD.
Telephone health coaching interventions in COPD
Many self-management interventions involve group-based
support or one-to-one consultations; a less expensive deliv-
ery option is potentially by telephone. Telephone health
coaching is distinct from tele-health, where remote tech-
nology is used to monitor disease. Telephone health coach-
ing has been described as: ‘A method of patient education
that guides and prompts a patient to be an active partici-
pant in behaviour change. Coaching involves an interactive
approach with the patient that helps to identify impedi-
ments to behaviour change, and methods of teaching and
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and maintain improved health status. Goal setting and
empowerment are important features’ [29]. A rapid review
of telephone coaching for long-term conditions reported
potential benefits on self-efficacy, health behaviour and
health status [30]. However, the evidence for telephone
coaching support in COPD is limited. Walters and col-
leagues undertook an RCT of telephone health mentoring
in patients with COPD in Australia and reported improved
self-management capacity, lower anxiety, but no effect on
health related quality of life [18] and that the telephone
intervention was favourably received [31]. A small RCT of
a telephone support intervention following hospital dis-
charge increased patient self-efficacy for self-management
of their condition [32] and a trial of 172 patients receiving
follow-up telephone calls after pulmonary rehabilitation
suggested modest additional improvements [33]. A study
of a two-week telephone supported intervention in 21 pa-
tients with stable but severe COPD [34] significantly in-
creased domiciliary activity levels, exercise capacity, and
quality of life scores, although there was no control group.
Although the evidence among COPD patients is lim-
ited, physical activity counselling and motivational inter-
viewing by telephone have shown some success in older
primary care patients [35] and long-term cancer survi-
vors [36]. An evaluation of a telephone care manage-
ment service for people with poorly controlled diabetes
reported improvement in HbA1c, blood pressure and
body mass index [37]. A systematic review of telephone
interventions for physical activity in healthy and patient
populations reported positive outcomes in 69% of stud-
ies [38]. Factors associated with more positive outcomes
were intervention duration of at least six months and
greater numbers of telephone contacts.
Need for a trial
There is an absence of research evidence about the ef-
fectiveness of self-management interventions in primary
care for people who report only mild symptoms of their
COPD. This is important, as access to services may be
on the basis of symptoms, rather than disease severity
and mild symptoms may not mean that airflow obstruc-
tion is also mild. Ongoing trials of self-management will
not address this need. With the interest in case-finding
for COPD in primary care it is important to identify ef-
fective interventions, so as to inform care for this patient
group. Established self-management programmes for
highly symptomatic patients are not necessarily relevant
for this group.
The main aim of this phase III trial is to determine whether
telephone health coaching to support self-management im-
proves health-related quality of life at 12 months follow-
up post-randomisation compared with usual primary care.
Additional aims will determine whether the interventionimproves self-reported and objective physical activity,
smoking and self-management behaviours, psychological
morbidity and self-efficacy. We will examine the experi-
ence of participants who were offered the supported self-
management intervention and assess the cost-effectiveness
of the supported self-management intervention.
Methods
Design
PSM COPD is a multi-centre RCT of a telephone health
coaching intervention to support self-management com-
pared with usual care for people with COPD with mild
dyspnoea.
Study setting
Seventy general practices within England. Additional
practices may be added if necessary to meet recruitment
targets.
Study population
Patients are identified as eligible if they are:
– On the practice COPD register, thus have
respiratory symptoms.
– Have mild dyspnoea (MRC grades 1 (only breathless
on strenuous exercise) or 2 (only get short of breath
when hurrying on level ground or up a slight hill)).
– Have a FEV1/FVC < 0.7 after post-bronchodilator
spirometry (consistent with current UK guidance [39])
at the baseline assessment. If there is a contraindication
to spirometry or the person refuses, a spirometry result
within 18 months, may be used, provided the print out
can be reviewed and the quality of the test established.
– Aged 18 years or over.
Exclusion criteria
– Potential participants are excluded if they report
their level of dyspnoea to be MRC 3 or greater.
– GPs are asked to exclude participants who, in their
opinion, it would be inappropriate for the research
team to invite to take part in the trial (e.g. terminal
disease, severe psychiatric disorder).
Patient invitation
Patients identified from COPD registers in general prac-
tices receive a letter of invitation on their general practice
headed paper, information brochure, patient information
leaflet (PIL) and a reply slip including the MRC dyspnoea
scale. Patients are asked to return their reply slip with
their contact details and MRC dyspnoea level to the re-
search team who contact them to book an assessment at
their GP surgery. Participant flow through the study is
summarised in Figure 1.
Figure 1 Study flow diagram.
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Baseline assessments take place in a room at the patient’s
GP practice. Patients attending baseline assessments discuss
the trial with the researcher and provide written consent to
participate. Permission is also sought to contact participants
for future research studies. Post-bronchodilator spirometry
is undertaken according to ATS/ERS 2005 guidelines [40]
and carried out by research nurses and researchers
trained to high standards using a short modified programme
modelled on the ARTP Spirometry course. FEV1 and FVC
are measured using the Easy One spirometer (ndd,
Switzerland). Patients are administered 400 micrograms
salbutamol through a spacer, and asked to rest for 20 mi-
nutes prior to undergoing spirometry. Easy on-PC soft-
ware is used to read and interpret the spirometry outputs.
COPD is confirmed among patients with respiratory
symptoms if their FEV1/FVC ratio is less than 0.7. All
spirometry results are provided for their GP. Patients’
height is measured to the nearest cm using a practice-based
tape measure (wall mounted) or a portable stadiometer
(or estimated using arm-span). Weight (to the nearest
0.1 kg) is measured using GP configured scales by re-
search assistants.During the assessment appointment patients also complete
a questionnaire including all the measures collected as
outcomes, plus demographic information.
Participants are fitted with a GENEactiv wrist worn ac-
celerometer to be worn for 7 days and returned by post in
a pre-paid envelope.
Allocation to trial arm
When a patient is identified as eligible for the study, and has
given written, informed consent to take part, the researcher
randomises the patient using a web-based programme
hosted by the Primary Care Clinical Trials Unit (PC-CTU),
University of Birmingham. Centre specific randomisa-
tion lists were produced by a statistician at the trials
unit. Participants are individually randomised, stratified
by centre. The four recruitment centres are Birmingham
and West-Midlands South; Greater Manchester; North
West Midlands and Oxfordshire/Gloucestershire. Only
the PC-CTU have access to the allocation sequence.
Usual care
The usual care group receives a standard information leaf-
let about self-management of COPD. The 13 page leaflet
Sidhu et al. BMC Pulmonary Medicine  (2015) 15:16 Page 5 of 11gives a definition of COPD, a detailed description of asso-
ciated symptoms, how the illness can be managed with
the use of inhalers, how to treat exacerbations, and details
of other resources (British Lung Foundation, Smokefree-
NHS Choices) which the patient might find useful.
Intervention
The intervention comprises a self-management package
of four components: smoking cessation advice; encourage-
ment to become physically active; correct inhaler tech-
nique and medication adherence. For those participants
with recurrent exacerbations who have an action plan and
rescue pack of antibiotics or steroids, there is an explor-
ation of their confidence in identifying an exacerbation
early and commencement of medication.
In keeping with best practice the intervention includes
education, monitoring and assessment of progress and tea-
ches skills with the aim of increasing self-efficacy [41-43].
We have also taken into account the best evidence for the
promotion of physical activity [38,44,45].
The intervention is delivered by telephone by a nurse with
one initial 35–60 minute coaching session one week post
randomisation followed by three 15–20 minute telephone
contacts over a three month period (at approximately weeks
3, 7 and 11) with individually tailored written supportiveTable 1 Summary of intervention components
Timing Telephone
Week 1 Timing of last check of inhaler. If not checked, encourage to get t
Smoking behaviours and encouragement to contact smoking cess
Current physical activity levels and breathlessness, goal to increase
Discussion of management of exacerbations, do they have an acti
use of rescue pack.
Week 3 Discussion of progress with goals set in previous session and any
Review of physical activity levels and setting of new goals.
Discussion of smoking, medication management and action plann
Week 7 Discussion of progress with goals set in previous session and any
Review of physical activity levels and setting of new goals.
Discussion of smoking, medication management and action plann
Week 11 Discussion of progress with goals set in previous session and any
Review of physical activity levels and setting of new goals.
Discussion of smoking, medication management and action plann
Week 16 None
Week 24 Nonematerials following telephone contacts (e.g. summary
of goals agreed, physical activity diary, contact details
for local services, information leaflet showing correct in-
haler technique). This is followed by standard written
prompts/information at 16 and 24 weeks. The first con-
sultation addresses all the elements of the intervention,
with subsequent ones addressing physical activity and
other elements as appropriate. The intervention compo-
nents are summarised in Table 1.
Smoking cessation
The nurse provides information about the health conse-
quences of smoking and sends a booklet with details about
the benefits of smoking cessation. The pros and cons for the
individual of smoking cessation are discussed. Participants
are encouraged to commit to approaching the smoking ces-
sation service and to set a goal to read the smoking cessa-
tion literature or contact the service. Any goals are reviewed
at subsequent telephone consultations and discrepancy be-
tween goals and actions discussed. Participants willing to
consider smoking cessation are encouraged to seek social
support from family and friends in their quit attempt. Writ-
ten prompts also provide information about local smoking
cessation services in case of relapse or for those not ready to
change early on in the intervention period.Postal
echnique checked. Physical activity booklet
Physical activity diary
ation service. Pedometer with instructions
Smoking booklet (smokers only)
activity and record in diary. Inhaler technique instruction leaflet
on plan, confidence with
barriers to achieving goals. Information on opportunities for
physical activity in the locality
Information leaflet: What are SMART goals?
ing as required.
SMART goals sheet
barriers to achieving goals. SMART goals sheet
ing as required.
barriers to achieving goals. SMART goals sheet
ing as required.
SMART goals sheet
Information on opportunities for
physical activity in the locality
Leaflet on tips for sustaining
physical activity
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In terms of promotion of physical activity, the intervention
is underpinned by Social Cognitive Theory [46] and aims
for participants to achieve the national recommendation
for 150 minutes of moderate intensity physical activity each
week. The first coaching session centres on uptake of phys-
ical activity, reduction of inactivity [47] and focuses on
enhancing motivation, self-efficacy for physical activity,
overcoming barriers and developing appropriate activity
plans and feelings and fears about physical activity, particu-
larly in relation to breathlessness. The final stage of the ses-
sion involves developing a physical activity goal for the next
telephone call. Participants are posted a pedometer to be
used as a motivational tool and to assist participants in quan-
tifying the amount of activity they are achieving each day/
week. Previous research with other populations has reported
pedometers to be effective in increasing the number of steps
that individuals take per day [48]. Following the first session
a booklet on physical activity and COPD, a diary for record-
ing their physical activity and a reminder of their goals are
posted. The follow-up telephone calls focus on goal setting
for increasing physical activity and intensity of activity and
prevention of relapse back to sedentary behaviour.
Medication management
The nurse asks about medication adherence, ascertains
confidence with inhaler technique and ascertains when
technique was last checked by a health professional. Par-
ticipants who have not had a recent inhaler check are
asked to set a goal to have it checked at a routine prac-
tice nurse/GP appointment or by their local pharmacist,
and to ask for an annual check. Participants are posted
written instructions for using their inhaler/s.
If participants have reported difficulties in remembering
to take their medications they are encouraged to self-
monitor their behaviour with a written log, to restructure
their physical environment to prompt their memory, to
consider a medication box or alarm for a reminder, or to
seek support from a partner.
Participants are asked about exacerbations and use of
antibiotics or steroids for these. Their ability to recog-
nise the symptoms of an exacerbation is checked. People
who have been given a prescription to start antibiotics/
steroids themselves will be asked about their confidence
in starting this medication and asked to describe the last
time they had an exacerbation and when and how they
made the decision to start their rescue medication. People
who are not confident in the use of their action plan are
asked to discuss this with their GP or practice nurse at
their next routine appointment.
Intervention fidelity
A sample of telephone consultations are being recorded
with the participants consent. These will be assessedaccording to delivery of the planned components, the use
of behavioural change techniques and patient centred ap-
proach. The nurses delivering the intervention record the
number of contacts and actions taken; these records will
be used to assess the proportion of the intervention par-
ticipants who participated in the intervention, the number
of calls per participant and the number who completed all
six intervention contacts.
Outcomes
The primary outcome is health related quality of life using
the St Georges Respiratory Questionnaire (SGRQ) [49]
which has previously been shown to be responsive in a
population with less advanced COPD [50]. The primary
endpoint is 12 months from randomisation.
Secondary outcomes: self-reported health behaviours
[smoking and physical activity (IPAQ)] [51], self-management
activities, psychological morbidity (Hospital Anxiety and
Depression Scale) [52], self-efficacy for managing their
COPD and undertaking physical activity, MRC dyspnoea
scale [53], health care utilisation (primary care consulta-
tions for COPD; prescriptions for antibiotics for COPD;
hospital admissions for COPD; attendance at smoking ces-
sation service), EuroQoL EQ-5D-5 L [54], physical activity
at 1 year measured by accelerometry. Table 2 summarises
the outcome measures and timing of assessment.
We ask participants randomised to the intervention to
complete exercise diary logs that detail the dose and type
of physical activity completed during weeks 3, 7, 11 of
the intervention. These logs are completed at the end of
support calls. At six months all participants are asked
about attendance at a smoking cessation service. The re-
search nurses record duration of calls and any adverse
events reported by intervention participants.
Follow up assessments
Outcomes are measured at six months to determine short–
term changes to the end of the intervention and 1 year to
determine whether change is sustained.
Statistical justification for sample size
The sample size has been determined to detect a signifi-
cant difference in the SGRQ at 1 year. To have 80%
power to detect a difference of 4 points (which is the
minimal clinically significant difference [26] from a base-
line total value of 39 [50], with a standard deviation of
15) at the 5% level of significance, 445 evaluable partici-
pants are required. We aim to recruit 556 participants,
which allows for a 20% loss to follow-up.
This sample size is more than sufficient to detect an in-
crease in physical activity in the intervention group. Assum-
ing the intervention arm reaches 89 minutes of moderate
intensity physical activity/week, and the control arm 55 mi-
nutes (SD= 70 mins), for 90% power at a 5% significance
Table 2 Outcome measures and time of assessment
Baseline 6 months 12 months
St George’s Respiratory Questionnaire X X X
Breathlessness: MRC Dyspnoea Scale X X X
Self-management activities X X X
Health related quality of life: EUROQOL EQ-5D-5 L X X X
Psychological status: Hospital Anxiety and Depression Scale X X X
Physical activity measured by GENEactiv accelerometers X X
International physical activity Questionnaire (short) X X X
Stanford self-efficacy for COPD and physical activity X X X
Health care utilisation X X X
Post-bronchodilator spirometry X
Weight and height X
Demographic characteristics X
Current medications for lung problems X
Co-morbidities X
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(in absence of good COPD data, EXERT trial data used)
[55]. Accounting for 20% loss-to follow-up, we therefore
require a total of 225 patients. To estimate the power for
smoking cessation we have taken a smoking prevalence of
45% [56]. Estimates of the likely quit rate are 34% in the
intervention arm and 9% in the usual care arm (estimates
from Cochrane review of nurse-led interventions for
smoking cessation [53]). Our proposed sample size of 278
per group is sufficient to achieve power of 75%, at the 5%
significance level.
Analysis
All data will be analysed by intention to treat. A com-
parison between groups for the primary outcome mea-
sures (health related quality of life) will be made at 1 year
to assess the long-term effect of the self-management
intervention.
For outcomes measured on a continuous scale (HRQoL,
physical activity, EuroQol EQ-5D), analysis of covariance
will be used; i.e. a linear regression where the final score is
regressed against treatment group and adjusted for base-
line score. Model assumptions will be checked and a
transformation for Normality used if necessary. Binary
outcomes will be analysed using logistic regression and re-
current outcomes (e.g. number of hospital admissions)
will be analysed using Poisson regression with an offset
term for the length of follow-up. Differences between
treatment groups will be summarised with suitable effect
estimates (e.g. mean difference, relative rate) with 95%
confidence intervals. A 5% statistical significance level will
be used. Levels and patterns of missing data will be
assessed and summarised, and if appropriate, suitable
methods (e.g. regression imputation using baseline data)will be used to evaluate any effect this might have on the
conclusions.
We will undertake exploratory subgroup analyses to ex-
plore the effects of the intervention in a subgroup who ac-
tively engage with the intervention (through increased
physical activity, uptake of smoking cessation support or
checking of inhaler technique) and those who increase
their self-efficacy for COPD self-management. Addition-
ally we will explore effectiveness in subgroups by baseline
level of self-efficacy, depression and anxiety scores and
HRQoL and participant characteristics (age, sex, ethnicity
and number of co-morbidities).
Economic analysis
Within-trial analysis
The health economic analysis will estimate the cost-
effectiveness of the self-management intervention com-
pared with usual care. A cost-consequence analysis will
initially be reported, describing all the important results
relating to costs and consequences in the intervention and
control arm over the 1 year trial period. Subsequently, a
cost-utility analysis will be undertaken using patient re-
sponses to the EuroQoL EQ-5D-5 L questionnaire, to cal-
culate the cost per additional Quality-Adjusted Life Year
(QALY) gained over the same period. As there is evidence
that the EQ-5D (3-level version) is insensitive to change in
pulmonary rehabilitation interventions [57], the more re-
cently developed 5 level version will be used in this evalu-
ation. QALYs will be calculated using data on mortality
and EQ-5D-5 L responses at baseline, six and 12 months.
The base-case cost analysis will adopt an NHS perspec-
tive and will include costs of the intervention, usual care,
and condition-specific health care utilisation (primary and
secondary care) including emergency admissions for
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specific resource use, including standard care will be collected
from using patient questionnaires. Data on additional costs
of the intervention including practice nurse time, tele-
phone support, web-site support, written materials and
patient prompts, exercise, additional GP consultation time
and smoking cessation will be collected alongside the trial.
Data will also be collected on set up and implementation
costs such as staff training workshops and implementing
quality control measures. Unit costs will be obtained from
standard sources and health care providers, including
NHS reference costs. Information will also be collected on
time off work related to COPD and will enable analysis for
a broader societal cost perspective.
The robustness of the base-case results will be ex-
plored using sensitivity analysis. This will explore uncer-
tainties in the trial based data itself and the methods
employed to collect and analyse the data. Uncertainty will
be explored through the use of cost-effectiveness accept-
ability curves (CEACs), which will estimate the probability
that self-management is cost-effective at different cost per
QALY thresholds.
Model-based analysis
If the self-management intervention demonstrates effect-
iveness within the trial, a Markov model-based analysis
will also be undertaken to determine the cost per QALY
gained beyond the trial period. The model structure will
be informed by a number of complementary methods. It
will build on modelling work undertaken for two funded
COPD studies on case finding and self-management for
severe to moderate COPD which will include a review of
existing decision models in COPD, and incorporate pa-
tient pathways identified within this research framework.
The model will be populated using the information on the
costs and outcomes demonstrated within the trial and ex-
trapolated to estimate the long-term costs and effects.
The robustness of the model results will be explored
using sensitivity analysis. Deterministic sensitivity analysis
will vary point estimates for all important input parame-
ters within a range of possible values (confidence inter-
vals). Probability distributions around point estimates will
be used to explore the uncertainty in the confidence to be
placed on the results of the economic analysis, using prob-
abilistic sensitivity analysis to estimate CEACs. Differences
in cost and outcomes associated with patient character-
istics such as sex, age, smoking status and existing co-
morbidities may be explored through subgroup analysis,
dependent on data availability.
Qualitative process evaluation
Our primary research question is to explore the way in
which patients with mild COPD understand and respond
to a telephone coaching, self-management intervention.We will explore the acceptability and feasibility of the
intervention and investigate how and why patients use or
discard opportunities for self-care over a 12 month period.
Finally, we will explore if self-care behaviours promoted
by the intervention become embedded within day-to-day
routines.
We will undertake individual interviews with partici-
pants using a longitudinal study design over the course
of the trial. We will select up to 20 participants who
have received the intervention, and up to 10 participants
from the control group. Interviews will take place approxi-
mately six and 12 months post randomisation. Interviews
will continue until saturation is reached [58]. Participants
will be purposively sampled to ensure there is maximum
variation in the sample along the following key character-
istics: HRQoL, geography, gender and age.
Longitudinal approaches have been used to uncover
multiple perspectives about disease progression and care
provision among patients with end-stage COPD [59],
but little is known about changing perspectives among
patients with mild to moderate disease who are engaged in
self-care. A longitudinal qualitative research design makes
it possible to capture any changes in self-management tra-
jectories within the context of the experience of living with
and managing a chronic condition such as COPD.
Regulatory issues
Ethics approval
The study has received ethical and research governance
approval from the National Research Ethics Service
(Reference 13/WM/0206). The study will be conducted in
accordance with the recommendations for physicians
involved in research on human subjects adopted by the
18th World Medical Assembly, Helsinki 1964 and later
revisions.
Indemnity
The University of Birmingham holds the relevant insur-
ance policy for this study.
Sponsor
The University of Birmingham will act as the main spon-
sor for this study.
Funding
National Institute for Health Research School for Primary
Care Research (SPCR Project 174).
Publication policy
We will present the results to the TSC prior to publica-
tion. The investigators will be involved in reviewing drafts
of the manuscripts, abstracts, press releases and any other
publication arising from the study. Members of the TSC
will be listed and their contribution acknowledged, as will
Sidhu et al. BMC Pulmonary Medicine  (2015) 15:16 Page 9 of 11the funding source (NIHR School for Primary Care
Research). Authorship will be determined in accordance
with the ICMJE guidelines and other contributors will be
acknowledged.
Patient advisory group
A patient advisory group (PAG) has been set up, chaired
by Mr Michael Darby. This group is funded to meet at
quarterly intervals or according to need, and will advise
on the design, conduct, analysis and dissemination of
the study. The PAG will discuss issues raised by the CI
and report comment back to investigators.
Data management
All data will be stored on a password-protected web-
enabled database designed and hosted by the PC-CTRU.
Paper-based information will be held in locked filing
cabinets in the study office.
Trial steering committee
The Trial Steering Committee (TSC) has been convened
to provide overall supervision of the trial and ensure it is
in accordance with the principles of good clinical practice
and the relevant regulations. The TSC agreed the trial
protocol and will agree any protocol amendments. The
TSC also provide advice to the investigators on all aspects
of the trial. The TSC is chaired by Dr Hilary Pinnock
(University of Edinburgh). Dr Rupert Jones (Plymouth
University), Dr Jill Mollison (University of Oxford) and
Mrs Maireade Bird (patient representative) are members.
Data monitoring committee
We did not consider that a separate data monitoring
and ethics committee would have been useful, as this is
an unblinded study with no substantial risk and no early
termination rules. The final decision was made by the
TSC, who agreed to incorporate the functions of a DMC
into their terms of reference.
Discussion
This trial investigates the effectiveness and cost effective-
ness of a nurse-led telephone health coaching interven-
tion to support self-management for patients living with
mild symptoms of COPD.
There are many strengths of this study including: a
multi-centre study design incorporating a large sample
of GP practices representative of the general UK popula-
tion; it has a pragmatic design to accommodate real life
patient practices; spirometry is undertaken using trained
staff and quality assured; the intervention is underpinned
by behaviour change theory; there is an embedded longi-
tudinal qualitative study; and a full cost effectiveness ana-
lyses. As a result, this trial will inform practice across theUK and contribute to the current effort to support people
living with COPD.
Nevertheless, a multifaceted trial of this size brings a
number of challenges. First, we are approaching a number
of practices and identifying thousands of patients. Second,
ensuring that we identify suitable patients (meeting our
inclusion criteria) from GP databases can create difficul-
ties, as the accuracy of the diagnosis of COPD varies for
patients on GP COPD registers. Third, patients who have
relatively mild symptoms from the COPD may be less
likely to respond to our invitation. Even with relatively
mild dyspnoea, potential participants will suffer from ex-
acerbations and chest infections which delay their recruit-
ment and requires some flexibility in the delivery of the
intervention. Finally, co-ordinating baseline assessment
with patients and GP practices over four main sites is
challenging and will require considerable resources to ful-
fil our recruitment target.
This trial will contribute robust evidence about the ef-
fectiveness of a novel telephone health coaching interven-
tion to improve outcomes and delay disease progression
among people with mild COPD. The service might be a
template for delivery of a flexible intervention that can
reach large numbers of an under recognised population
and as such it has capacity to contribute significantly to
improving public health.
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